| Primary information |
|---|
| ID | antitb_1349, |
| Name | 9693108 |
| N-Terminal modification | Tenecin 1 Fragment 33-43 |
| C-Terminal Modification | YCNGKRVCVC |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | Internal disulphide bond |
| Chirality | Cyclic |
| Nature | 10 |
| Species | Natural |
| Strain | Larvae of tenebrio molitor(beetle) |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC 612 |
| Cell Line | MIC = >100 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 1998 |
| Cytotoxicity | Human erythrocyte |
| In vivo Model | NA |
| Lethal Dose | None |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | Membrane disruption as reported by membrane leaky assay |
| Other activities | NA |
| PMID | NA |
| Year of Publication | Antibacterial against MRSA, bacillus subtilis, E.coli, Shigella at 10-30 μg/ml |
Tertiary Structure
(Technique) | Not Predicted), |